Trials / Completed
CompletedNCT02002039
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
Erythropoietin in Perinatal Asphyxia: A Randomized Placebo Controlled Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Sheri Kashmir Institute of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 6 Hours
- Healthy volunteers
- Not accepted
Summary
Whether Erythropoietin improves the neurological outcomes of neonates with perinatal asphyxia.
Detailed description
will be a randomized trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erythropoietin | 500 units /kg /day every other day for 5 doses |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2013-12-05
- Last updated
- 2016-10-14
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02002039. Inclusion in this directory is not an endorsement.